Pricing Log in Create free account

Crescent Biopharma, Inc. (CBIO) vs Neurogene Inc. (NGNE)

Crescent Biopharma, Inc. and Neurogene Inc. are both Biotechnology companies. Crescent Biopharma, Inc. and Neurogene Inc. are of similar size ($520.3M and $507.0M). Across the 9 metrics below, Neurogene Inc. leads on 5 and Crescent Biopharma, Inc. on 4.

Valuation

Metric CBIO NGNE Biotechnology median
P/E n/m n/m 10.85
P/S 340.86 n/m 9.49
P/B 2.61 2.69 2.18
Price to free cash flow n/m n/m 25.85
EV/EBITDA n/m n/m 0.70
EV/Sales 230.77 n/m 8.99
Earnings yield (49.41%) (19.40%) (31.76%)
Free cash flow yield (17.30%) (15.00%) (21.84%)

Profitability

Metric CBIO NGNE Biotechnology median
Gross margin 19.72% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (101.95%) (45.32%) (50.82%)
Return on assets (88.26%) (41.02%) (46.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBIO NGNE Biotechnology median
Revenue growth (TTM) (45.09%) — 6.96%
EPS growth (last fiscal year) 78.20% 0.93% 29.88%
Revenue growth, 5-year CAGR 257.77% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBIO NGNE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.66 10.64 4.84
Net debt to EBITDA 1.40 2.57 1.01

Dividend

Metric CBIO NGNE Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric CBIO NGNE Biotechnology median
Market cap 507.02m 520.30m 163.56m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack